SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2277thanks Jim. That would have given me almost 2 months rent for a minute's woIan@SI-5/20/2010
2276It was just 520 shares traded around those levels.rkrw-5/20/2010
2275Something real weird with MNTA trading this afternoon. I received the followingIan@SI-5/20/2010
2274online.wsj.com * MAY 17, 2010 Merck Move Shows Hurdles to Developing BiotecIan@SI-5/17/2010
2273Results of iHub Surveys on Generic Lovenox/Copaxone: siliconinvestor.comDewDiligence_on_SI-5/15/2010
2272News Breaks May 13, 2010 07:36 EDT MNTA theflyonthewall.com: Momenta Pharma caArthur Radley-5/14/2010
2271J. Woodcock, FDA/CDER to Teva Neurosciene, Inc. - Petition Denial You can downlidos-5/14/2010
2270This is later Dow Jones version of the story with some annotations and hyperlinkDewDiligence_on_SI-5/13/2010
2269Now all the FDA has to do is reject SNY’s Citizen Petition on Lovenox and the coDewDiligence_on_SI-5/13/2010
2268 * MAY 13, 2010, 2:38 P.M. ET UPDATE: FDA Rejects Teva Petition Against GeneIan@SI-5/13/2010
2267Please vote in new survey on generic Copaxone: siliconinvestor.comDewDiligence_on_SI-5/12/2010
2266MNTA ‘ReadMeFirst’ updated: <i>liquidity and cash usage; 1Q10 financial rDewDiligence_on_SI-5/11/2010
2265<i>>Hasn't the CEO previously said he likes to keep at least a yearDewDiligence_on_SI-5/7/2010
2264Hasn't the CEO previously said he likes to keep at least a year and a half&#rkrw-5/7/2010
2263More on the same topic: siliconinvestor.comDewDiligence_on_SI-5/7/2010
2262Something like that - no fat finger required. Runs untouched by human hand. nyttom pope-5/7/2010
2261MNTA Liquidity and Cash Usage (updated for 1Q10 results): siliconinvestor.comDewDiligence_on_SI-5/7/2010
2260Teva is playing its cards close to the chest, so it's hard to say how sophisDewDiligence_on_SI-5/6/2010
2259Why is it good for Teva? Do they have technology enabled biogenerics planned?rkrw-5/6/2010
2258Wheeler’s comments (with some context) on the new FoB legislation: siliconinvesDewDiligence_on_SI-5/6/2010
2257BioInvent and ThromboGenics Announce Positive Topline Results from Phase II VTE nigel bates-5/6/2010
2256i'm no chartist, but MNTA is definitely brushing up against a resistance linmpower90024-4/23/2010
2255Nothing I'm aware of (eom).DewDiligence_on_SI-4/22/2010
2254Not necessarily directed at you, Dew, but does anyone have any idea what in the Jeffry K. Smith-4/22/2010
2253That’s right—2014 is about the earliest M118 could conceivably be on the market.DewDiligence_on_SI-4/12/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News